Pharma/Biotech – USA, Europe Regulatory News, July 2023 Vol. 1
USA
CMS IRA Updates Bring No Significant Strategic Shift for Manufacturers
Despite ongoing lawsuits and thousands of public comments, CMS has made limited adjustments to the drug price negotiation...
Biotech Regulatory News, EMA, EU Regulatory News, FDA, GCP Guideline, MHRA, Pharma Regulatory News, Regulatory News, RWD, RWE, USA Regulatory News